Tuesday, September 22, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $338.98 +0.85%
MSFT $501.61 +1.59%
GOOGL $354.97 +1.55%
AMZN $258.45 +1.87%
TSLA $375.30 +3.03%
META $741.25 +11.34%
NVDA $227.38 +2.30%
JPM $352.04 +0.68%
BTC $38.25 +6.52%
ETH $26.36 +4.69%
AAPL
$338.98
▲ 0.85%
MSFT
$501.61
▲ 1.59%
GOOGL
$354.97
▲ 1.55%
AMZN
$258.45
▲ 1.87%
TSLA
$375.30
▲ 3.03%
META
$741.25
▲ 11.34%
NVDA
$227.38
▲ 2.30%
JPM
$352.04
▲ 0.68%
Bloomberg Markets
Once seen as a lucrative alternative to the PGA, LIV Golf instead landed in the rough, part of an abortive effort by Saudi Arabia to exert soft power. Now LIV’s future is uncertain amid a search for new funding. (Source: Bloomberg)
business  Aug 27, 2026
Bloomberg Markets
About one month after Japan and the US joined forces to prop up the yen, strategists say the intervention succeeded in slowing the currency’s short-term slide but did little to alter the forces driving its longer-term decline.
business  Aug 27, 2026
Bloomberg Markets
Revolution Medicines won US approval for a breakthrough pill that lengthens the lives of patients with advanced pancreatic cancer, a major advance against one of the hardest-to-treat tumor types. The once-daily drug carries a list price of more than $475,000 a year, making it one of the most expensive cancer treatments in history. The company branded it Rasonque and made it available starting Wednesday. It’s one of the first medicines to broadly target RAS, a protein tied to tumor growth that’s
business  Aug 27, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free